SCHEMBL21452872

SCHEMBL21452872

C[C@H]1CCCN(c2ccnc(-c3ccc(OC(F)(F)F)c(F)c3)c2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.39
▸ SYK P43405 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ GRM2 Q14416 4/20 0.38
▸ NSD2 O96028 1/20 0.37
▸ FAAH O00519 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ CHRM5 P08912 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ CHRM3 P20309 1/20 0.37
▸ PDE2A O00408 1/20 0.36
▸ GALR2 O43603 1/20 0.36
▸ GALR1 P47211 1/20 0.36
▸ USP30 Q70CQ3 2/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ TRPA1 O75762 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21453061 1.00 HRH4 (0.39) HRH4SYKHRH3GRM2NSD2
SCHEMBL21453056 0.89 PDE2A (0.38) HRH4SYKGRM2NSD2FAAH
SCHEMBL21452938 0.89 MAPK1 (0.39) HRH4SYKHRH3GRM2FAAH
SCHEMBL21452940 0.88 ABL1 (0.42) HRH4FAAHPDE2A
SCHEMBL21434003 0.85 FAAH (0.41) HRH4SYKGRM2FAAHKDM4E
SCHEMBL21453065 0.85 HRH4 (0.39) HRH4GRM2KDM4EHTTLRRK2
SCHEMBL21434096 0.84 SYK (0.45) HRH4SYK
SCHEMBL21434015 0.83 ABL1 (0.42) GRM2FAAHCHRM2PDE2ANTRK1
SCHEMBL21433998 0.81 DKK1 (0.42) CHRM2CHRM5CHRM1CHRM3NTRK1
SCHEMBL21433991 0.79 SCN9A (0.46) CHRM2CHRM1PDK2KDM4ENTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback